About
Basic Data Updated:
12 days agoThe manufacturing of formulations is carried out by Emcure Pharmaceuticals Ltd, a company that is highly engaged in this field. Tablets, capsules (both soft gel capsules and hard-gel capsules), and injectables are among the products that the company offers. With four manufacturing facilities located in Pune and one in Jammu, Emcure Pharmaceuticals Ltd has established a strong presence in the industry. These facilities have been accredited by renowned regulatory authorities such as USFDA (US Food and Drug Administration), TGA (Therapeutic Goods Administration), and Canada Food and Drug Administration. They are also fully compliant with the CGMP (Current Good Manufacturing Practices) standards. In addition to its manufacturing capabilities, Emcure Pharmaceuticals Ltd also boasts three dedi... Read More
Industry
Company Details
- Location
Pune, Maharashtra, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | U24231PN1981PLC024251 |
| Company No. | 024251 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 16 Apr 1981 |
| Date of AGM | 10 Jul 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Pune |
Products or Services related to Emcure Pharmaceuticals Limited
Allopathic Cough Syrup
Antipyretic and Analgesic API
Torex Cough Syrup
Pharmaceutical Medicine
Financials of Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.17% decrease. The company also saw a substantial fall in profitability, with a 64.18% decrease in profit. The company's net worth moved up by a moderate rise of 7.55%.
Enhance accessibility to Emcure Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Emcure Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Emcure Pharmaceuticals Limited
Unlock and access historical data on people associated with Emcure Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
SM
Satish Mehta
Managing DirectorAppointment Date: 16-Apr-1981
Status: Current
TS
Tajuddin Shaikh CFOAppointment Date: 16-Apr-2021
Status: Current
CS
Chetan Sharma Company SecretaryAppointment Date: 01-Jun-2023
Status: Current
Board Members(10)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tata Capital Financial Services Limited Creation Date: 20 Dec 2023 | ₹50.00 Cr | Open |
Others Creation Date: 09 Oct 2023 | ₹50.00 Cr | Open |
Others Creation Date: 04 May 2023 | ₹225.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emcure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emcure Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Future Generali India Life Insurance Company Limited
Active
17 years 6 months Palamadai Jayakumar is a mutual person
Recent activity within the organization
Charges
A charge with Others of Rs. 100.00 cr registered on 27 Jun 2022 with Charge ID 100590827 was modified on 24 Jan 2024.
24 Jan 2024Charges
A charge with Tata Capital Financial Services Limited amounted to Rs. 50.00 cr with Charge ID 100843954 was registered on 20 Dec 2023.
20 Dec 2023Charges
A charge with Axis Bank Limited of Rs. 52.00 cr registered on 19 Mar 2018 with Charge ID 100161882 was modified on 06 Nov 2023.
06 Nov 2023Charges
A charge registered on 30 Mar 2017 via Charge ID 100087843 with Axis Bank Limited was fully satisfied on 06 Nov 2023.
06 Nov 2023Charges
A charge registered on 30 Mar 2021 via Charge ID 100452801 with Others was fully satisfied on 10 Oct 2023.
10 Oct 2023
Recent News, Updates & Announcement
Emcure Pharmaceuticals Limiteds Initial Public Offering.Global Legal Chronicle 09 Jan 2024
- Vanta Bioscience signs Rs 29 Cr deal with Emcure Pharma.
BioSpectrum India 08 Apr 2019
- Emcure launches generic metastatic breast cancer drug in India.
The company will manufacture the product at its plant at Hinjewadi in Pune and market it at a cost which will be approximately 40 per cent less than the innovator brand Emcure Pharmaceuticals said .
PTI 03 Apr 2019
Frequently asked questions
What is the Incorporation or founding date of Emcure Pharmaceuticals Limited?
